Hsbc Holdings PLC Adma Biologics, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 29,736 shares of ADMA stock, worth $515,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,736
Previous 21,550
37.99%
Holding current value
$515,919
Previous $430,000
18.37%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$323 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$316 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$258 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$196 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$96 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.41B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...